Medical - Pharmaceuticals - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

Trulieve Cannabis Corp.

TRLV

Market Cap $2.01B

Dividends 0.0%

P/E Ratio -27.1

Revenue $271M

Net Income -$406M

Profit Margin -149.8%

Employees 5K

View Stock

Corbus Pharmaceuticals Holdings Inc

CRBP

Market Cap $202.14M

Dividends 0.0%

P/E Ratio -1.7

Revenue $0.00

Net Income -$35M +98.4%

Profit Margin

Employees 28

View Stock

Corbus Pharmaceuticals Holdings, Inc.

0SZI.L

Market Cap $202.14M

Dividends 0.0%

P/E Ratio -1.7

Revenue $0.00

Net Income -$35M +98.4%

Profit Margin

Employees 28

View Stock

OncoCyte Corporation

0KCC.L

Market Cap $135.46M

Dividends 0.0%

P/E Ratio -2.7

Revenue $239k -53.9%

Net Income -$11.3M +15.6%

Profit Margin -4711.3%

Employees 46

View Stock

Adicet Bio Inc

ACET

Market Cap $84.7M

Dividends 0.0%

P/E Ratio -0.8

Revenue $0.00

Net Income -$21.4M -31.6%

Profit Margin

Employees 152

View Stock

Adicet Bio, Inc.

0HX7.L

Market Cap $84.7M

Dividends 0.0%

P/E Ratio -0.8

Revenue $0.00

Net Income -$21.4M -31.6%

Profit Margin

Employees 152

View Stock

Qualigen Therapeutics Inc

QLGN

Market Cap $15.84M

Dividends 0.0%

P/E Ratio -0.1

Revenue $0.00

Net Income -$4.19M +148.5%

Profit Margin

Employees 4

View Stock

AIxCrypto Holdings, Inc.

AIXC

Market Cap $15.84M

Dividends 0.0%

P/E Ratio -0.1

Revenue $0.00

Net Income -$4.19M +148.5%

Profit Margin

Employees 4

View Stock

Cyclacel Pharmaceuticals Inc

CYCC

Market Cap $11.31M

Dividends 0.0%

P/E Ratio -0.2

Revenue $336.00

Net Income -$405.00 -69.3%

Profit Margin -120.5%

Employees 2.02K

View Stock

Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10

CYCCP

Market Cap $11.31M

Dividends 0.0%

P/E Ratio -0.2

Revenue $336.00

Net Income -$405.00 -69.3%

Profit Margin -120.5%

Employees 2.02K

View Stock

Bio Green Med Solution, Inc.

BGMS

Market Cap $11.31M

Dividends 0.0%

P/E Ratio -0.2

Revenue $336.00

Net Income -$405.00 -69.3%

Profit Margin -120.5%

Employees 2.02K

View Stock

Satellos Bioscience Inc. Common Stock

MSLE

Market Cap $11.16M

Dividends 0.0%

P/E Ratio -4.4

Revenue $0.00

Net Income -$11.4M +103.6%

Profit Margin

Employees 14

View Stock

MedAvail Holdings Inc

MDVL

Market Cap $2.91M

Dividends 0.0%

P/E Ratio 0.0

Revenue $405k -96.4%

Net Income -$5.79M -50.6%

Profit Margin -1429.9%

Employees 279

View Stock

MedAvail Holdings, Inc.

MDVLQ

Market Cap $2.91M

Dividends 0.0%

P/E Ratio 0.0

Revenue $405k -96.4%

Net Income -$5.79M -50.6%

Profit Margin -1429.9%

Employees 279

View Stock